Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 220 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 2741 results:
Author Title [ Type(Desc)] Year
Journal Article
A. Lawson, West, J., Aithal, G. P., and Logan, R. F., Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association, Aliment Pharmacol Ther, vol. 21, pp. 401-5, 2005.
T. M. Anssar, Leitzmann, M. F., Linker, R. A., Meier, C., Becker, C., Jick, S., Sahm, K., Platten, M., Hau, P., and Seliger, C., Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma, Cancer Med, 2019.
E. Ford, Sheppard, J., Oliver, S., Rooney, P., Banerjee, S., and Cassell, J. A., Automated detection of patients with dementia whose symptoms have been identified in primary care but have no formal diagnosis: a retrospective case-control study using electronic primary care records, BMJ Open, vol. 11, p. e039248, 2021.
K. W. Littink, Stappers, P. T. Y., Riemslag, F. C. C., Talsma, H. E., van Genderen, M. M., Cremers, F. P. M., Collin, R. W. J., and van den Born, L. I., Autosomal Recessive NRL Mutations in Patients with Enhanced S-Cone Syndrome, Genes (Basel), vol. 9, 2018.
B. A. Dickerman, Garcia-Albeniz, X., Logan, R. W., Denaxas, S., and Hernan, M. A., Avoidable flaws in observational analyses: an application to statins and cancer, Nat Med, 2019.
I. J. Douglas, Bhaskaran, K., Batterham, R. L., and Smeeth, L., Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care, PLoS Med, vol. 12, p. e1001925, 2015.
K. van Brunt, Curtis, B., Ivanyi, T., Balogh, E., Chalkiadaki, C., MacLachlan, S., Neasham, D., and Raluy-Callado, M., Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin, Diabetes Ther, vol. 7, pp. 793-807, 2016.
S. F. Lanes, Rodrigeuz, L. A., and Hwangg, E., Baseline risk of gastrointestinal disorders among new users of meloxicam, ibuprofen, diclofenac, naproxen and indomethacin, Pharmacoepidemiol Drug Saf, vol. 9, pp. 113-7, 2000.
Y. Li, Rao, S., Solares, J. R. A., Hassaine, A., Ramakrishnan, R., Canoy, D., Zhu, Y., Rahimi, K., and Salimi-Khorshidi, G., BEHRT: Transformer for Electronic Health Records, Sci Rep, vol. 10, p. 7155, 2020.
J. Stowe, Andrews, N., Wise, L., and Miller, E., Bell's palsy and parenteral inactivated influenza vaccine, Hum Vaccin, vol. 2, pp. 110-2, 2006.
J. P. Sheppard, Stevens, S., Stevens, R., Martin, U., Mant, J., Hobbs, F. D. R., and McManus, R. J., Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension, JAMA Intern Med, vol. 178, pp. 1626-1634, 2018.
D. B. Wolfson, Best, A. F., Addona, V., Wolfson, J., and Gadalla, S. M., Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophy, Stat Methods Med Res, p. 962280218804275, 2018.
R. Alsaggaf, St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., Liu, Z., Koshiol, J., Bauer, A. J., Wagner, K. R., Greene, M. H., Amr, S., and Gadalla, S. M., Benign tumors in myotonic dystrophy type I target disease-related cancer sites, Ann Clin Transl Neurol, vol. 6, pp. 1510-1518, 2019.
P. Imfeld, Bodmer, M., Jick, S. S., and Meier, C. R., Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis, Drug Saf, vol. 38, pp. 909-19, 2015.
A. Palmaro, Dupouy, J., and Lapeyre-Mestre, M., Benzodiazepines and risk of death: Results from two large cohort studies in France and UK, Eur Neuropsychopharmacol, vol. 25, pp. 1566-77, 2015.
F. Giorgianni, Ernst, P., Dell'Aniello, S., Suissa, S., and Renoux, C., Beta 2 agonists and the incidence of Parkinson's disease, Am J Epidemiol, 2020.
C. McCourt, Coleman, H. G., Murray, L. J., Cantwell, M. M., Dolan, O., Powe, D. G., and Cardwell, C. R., Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study, Br J Dermatol, vol. 170, pp. 930-8, 2014.
C. R. Cardwell, Coleman, H. G., Murray, L. J., Entschladen, F., and Powe, D. G., Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort, Int J Epidemiol, vol. 42, pp. 1852-61, 2013.
B. M. Hicks, Murray, L. J., Powe, D. G., Hughes, C. M., and Cardwell, C. R., beta-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort, Ann Oncol, vol. 24, pp. 3100-6, 2013.
C. Renoux, Dell'Aniello, S., Brenner, B., and Suissa, S., Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism, Pharmacoepidemiol Drug Saf, vol. 26, pp. 554-560, 2017.
S. J. Sinnott, Mansfield, K. E., Schmidt, M., Bhaskaran, K., Smeeth, L., Nitsch, D., and Tomlinson, L. A., Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort study, BMJ Open, vol. 7, p. e018153, 2017.
J. Spoendlin, Meier, C., Jick, S. S., and Meier, C. R., Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1116-1123, 2016.
W. G. Dixon and Solomon, D. H., Bisphosphonates and esophageal cancer–a pathway through the confusion, Nat Rev Rheumatol, vol. 7, pp. 369-72, 2011.
E. Wright, Schofield, P. T., Seed, P., and Molokhia, M., Bisphosphonates and risk of upper gastrointestinal cancer–a case control study using the General Practice Research Database (GPRD), PLoS One, vol. 7, p. e47616, 2012.
C. Ang, Doyle, E., and Branch, A., Bisphosphonates as potential adjuvants for patients with cancers of the digestive system, World J Gastroenterol, vol. 22, pp. 906-16, 2016.
K. Donegan, Beau-Lejdstrom, R., King, B., Seabroke, S., Thomson, A., and Bryan, P., Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK, Vaccine, vol. 31, pp. 4961-7, 2013.
N. Ismail, Jordan, K. P., Kadam, U. T., Edwards, J. J., Kinnaird, T., and Mamas, M. A., Bleeding After Hospital Discharge Following Acute Coronary Syndrome: Incidence, Types, Timing, and Predictors, J Am Heart Assoc, vol. 8, p. e013679, 2019.
O. A. Oshagbemi, Franssen, F. M. E., van Kraaij, S., Braeken, D. C. W., Wouters, E. F. M., van der Zee, A. H. Maitlan, Driessen, J. H. M., and de Vries, F., Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD), Copd, pp. 1-8, 2019.
O. A. Oshagbemi, Franssen, F. M. E., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., van der Zee, A. H. Maitlan, Burden, A. M., and de Vries, F., Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality, Pharmacoepidemiol Drug Saf, vol. 27, pp. 1191-1199, 2018.
J. Gregson, Qizilbash, N., Iwagami, M., Douglas, I., Johnson, M., Pearce, N., and Pocock, S., Blood pressure and risk of dementia and its subtypes: a historical cohort study with long-term follow-up in 2.6 million people, Eur J Neurol, vol. 26, pp. 1479-1486, 2019.
C. A. Emdin, Rothwell, P. M., Salimi-Khorshidi, G., Kiran, A., Conrad, N., Callender, T., Mehta, Z., Pendlebury, S. T., Anderson, S. G., Mohseni, H., Woodward, M., and Rahimi, K., Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke, Stroke, vol. 47, pp. 1429-35, 2016.
J. A. H. Masoli, Delgado, J., Pilling, L., Strain, D., and Melzer, D., Blood pressure in frail older adults: associations with cardiovascular outcomes and all-cause mortality, Age Ageing, 2020.
J. Delgado, Bowman, K., Ble, A., Masoli, J., Han, Y., Henley, W., Welsh, S., Kuchel, G. A., Ferrucci, L., and Melzer, D., Blood Pressure Trajectories in the 20 Years Before Death, JAMA Intern Med, vol. 178, pp. 93-99, 2018.
N. Qizilbash, Gregson, J., Johnson, M. E., Pearce, N., Douglas, I., Wing, K., Evans, S. J. W., and Pocock, S. J., BMI and risk of dementia in two million people over two decades: a retrospective cohort study, Lancet Diabetes Endocrinol, vol. 3, pp. 431-436, 2015.
H. Strongman, Brown, A., Smeeth, L., and Bhaskaran, K., Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals, Br J Cancer, 2019.
W. A. Blumentals, Nevitt, A., Peng, M. M., and Toovey, S., Body mass index and the incidence of influenza-associated pneumonia in a UK primary care cohort, Influenza Other Respir Viruses, vol. 6, pp. 28-36, 2012.
S. Kent, Jebb, S. A., Gray, A., Green, J., Reeves, G., Beral, V., Mihaylova, B., and Cairns, B. J., Body mass index and use and costs of primary care services among women aged 55-79 years in England: a cohort and linked data study, Int J Obes (Lond), 2018.
K. Bhaskaran, Douglas, I., Forbes, H., dos-Santos-Silva, I., Leon, D. A., and Smeeth, L., Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults, Lancet, vol. 384, pp. 755-65, 2014.
W. G. Herrington, Smith, M., Bankhead, C., Matsushita, K., Stevens, S., Holt, T., Hobbs, F. D., Coresh, J., and Woodward, M., Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England, PLoS One, vol. 12, p. e0173515, 2017.
J. H. Driessen, Henry, R. M., van Onzenoort, H. A., Lalmohamed, A., Burden, A. M., Prieto-Alhambra, D., Neef, C., Leufkens, H. G., and de Vries, F., Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis, Calcif Tissue Int, vol. 97, pp. 104-12, 2015.
R. I. Furlano, Bloechliger, M., Jick, H., and Meier, C. R., Bone fractures in children with autistic spectrum disorder, J Dev Behav Pediatr, vol. 35, pp. 353-9, 2014.
A. Gonzalez-Perez, Ronquist, G., and Rodriguez, L. A. Garcia, Breast cancer incidence and use of antihypertensive medication in women, Pharmacoepidemiol Drug Saf, vol. 13, pp. 581-5, 2004.
A. Gonzalez-Perez and Rodriguez, L. A. Garcia, Breast cancer risk among users of antidepressant medications, Epidemiology, vol. 16, pp. 101-5, 2005.
V. Abbing-Karahagopian, Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., Hasford, J., Dijk, L., de Abajo, F. J., Weil, J. G., Grimaldi-Bensouda, L., Egberts, A. C., Reynolds, R. F., and Klungel, O. H., Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project, Curr Clin Pharmacol, vol. 9, pp. 130-8, 2014.
V. Navaratnam, Millett, E. R., Hurst, J. R., Thomas, S. L., Smeeth, L., Hubbard, R. B., Brown, J., and Quint, J. K., Bronchiectasis and the risk of cardiovascular disease: a population-based study, Thorax, vol. 72, pp. 161-166, 2017.
S. Langham, Wright, A., Shaw, H., Bryson, S., and O'Leary, S., Budget impact analysis of oral glycopyrronium bromide (Sialanar™) for the symptomatic treatment of severe sialorrhoea (Drooling) in the UK setting, Value in Health, vol. 20, p. A720, 2017.
M. Gokhale, Hattori, T., Evitt, L., Lenney, W., Nordstrom, B., Collins, J., Schultze, A., and Van Dyke, M. K., Burden of asthma exacerbations and health care utilization in pediatric patients with asthma in the US and England, Immun Inflamm Dis, 2020.
F. Rees, Doherty, M., Grainge, M., Lanyon, P., Davenport, G., and Zhang, W., Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999-2012, Arthritis Care Res (Hoboken), vol. 68, pp. 819-27, 2016.
I. Matthews, Duong, M., Parsons, V. L., Nozad, B., Qizilbash, N., Patel, Y., and Guimicheva, B., Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK, PLoS One, vol. 15, p. e0229224, 2020.
E. A. Yanni, Ferreira, G., Guennec, M., Y. Hahi, E., A. Ghachi, E., Haguinet, F., Espie, E., and Bianco, V., Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012, BMJ Open, vol. 8, p. e020528, 2018.
[Page last reviewed 4 March 2021]